Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    NCGC00024546-04

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 6Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Remote Trial Shows GABA Probiotic Improves Sleep, Lowers Stress
    Remote Trial Shows GABA Probiotic Improves Sleep, Lowers Stress

    20 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/groundbreaking-remote-clinical-trial-shows-gaba-producing-probiotic-improves-sleep-and-reduces-stress-302664754.html

    PR NEWSWIRE
    20 Jan 2026
    Share Share
    Legacy Pharmaceutical Packaging Issues Voluntary Nationwide Recall of Losartan Potassium Tablets
    Legacy Pharmaceutical Packaging Issues Voluntary Nationwide Recall of Losartan Potassium Tablets

    16 Mar 2019

    // FDA

    https://www.pharmacompass.com/pdf/news/legacy-pharmaceutical-packaging-llc-issues-voluntary-nationwide-recall-of-losartan-potassium-tablets-1552717015.pdf

    FDA
    16 Mar 2019
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.